Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study

R Chopard, M Badoz, C Eveno, F Ecarnot, N Falvo… - Thrombosis …, 2020 - Elsevier
Objectives The safety and efficacy of direct oral anticoagulants (DOACs) in intermediate-
high risk pulmonary embolism (PE) are unknown. The aims of the present study were to …
被引用次数：6 相关文章

Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study

R Chopard, M Badoz, C Eveno… - Thrombosis …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives The safety and efficacy of direct oral anticoagulants (DOACs) in intermediate-
high risk pulmonary embolism (PE) are unknown. The aims of the present study were to …

Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study

R Chopard, M Badoz, C Eveno… - Thrombosis …, 2020 - thrombosisresearch.com
Objectives The safety and efficacy of direct oral anticoagulants (DOACs) in intermediate-
high risk pulmonary embolism (PE) are unknown. The aims of the present study were to …

Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.

R Chopard, M Badoz, C Eveno, F Ecarnot… - Thrombosis …, 2020 - europepmc.org
Objectives The safety and efficacy of direct oral anticoagulants (DOACs) in intermediate-
high risk pulmonary embolism (PE) are unknown. The aims of the present study were to …
[PDF] hal.science

[PDF][PDF] Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study

R Chopard, M Badoz, C Eveno, F Ecarnot… - Thrombosis …, 2020 - hal.science
Objectives: The safety and efficacy of direct oral anticoagulants (DOACs) in intermediate-
high 37 risk pulmonary embolism (PE) are unknown. The aims of the present study were to …
[PDF] hal.science

[PDF][PDF] Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study

R Chopard, M Badoz, C Eveno, F Ecarnot, N Falvo… - hal.science
Objectives: The safety and efficacy of direct oral anticoagulants (DOACs) in intermediate-
high 37 risk pulmonary embolism (PE) are unknown. The aims of the present study were to …